News
AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Be...
AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years.
